Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285490696> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- W4285490696 endingPage "148" @default.
- W4285490696 startingPage "142" @default.
- W4285490696 abstract "On March 26, 2022, the First scientific and practical forum of the biopharmaceutical company Nanolek was held, dedicated to the issues of modern methods for the treatment of lymphoproliferative diseases using innovative targeted drugs, including Bruton tyrosine kinase inhibitor zanubrutinib. The leading Russian speakers showed the results of new clinical studies in the context of therapy of mantle cell lymphoma, Waldenstrom's disease, marginal zone lymphoma, as well as chronic lymphocytic leukemia. The algorithms for the management of patients, as well as the complex issues concerning the choosing therapy in case of relapses of non-Hodgkin lymphomas and chronic lymphocytic leukemia were discussed." @default.
- W4285490696 created "2022-07-15" @default.
- W4285490696 date "2022-07-15" @default.
- W4285490696 modified "2023-09-26" @default.
- W4285490696 title "Innovations in the therapy of oncohematological diseases" @default.
- W4285490696 doi "https://doi.org/10.26442/18151434.2022.2.201696" @default.
- W4285490696 hasPublicationYear "2022" @default.
- W4285490696 type Work @default.
- W4285490696 citedByCount "0" @default.
- W4285490696 crossrefType "journal-article" @default.
- W4285490696 hasBestOaLocation W42854906961 @default.
- W4285490696 hasConcept C126322002 @default.
- W4285490696 hasConcept C143998085 @default.
- W4285490696 hasConcept C151730666 @default.
- W4285490696 hasConcept C2777525834 @default.
- W4285490696 hasConcept C2777938653 @default.
- W4285490696 hasConcept C2778461978 @default.
- W4285490696 hasConcept C2779338263 @default.
- W4285490696 hasConcept C2779343474 @default.
- W4285490696 hasConcept C2779878957 @default.
- W4285490696 hasConcept C2780483514 @default.
- W4285490696 hasConcept C71924100 @default.
- W4285490696 hasConcept C86803240 @default.
- W4285490696 hasConceptScore W4285490696C126322002 @default.
- W4285490696 hasConceptScore W4285490696C143998085 @default.
- W4285490696 hasConceptScore W4285490696C151730666 @default.
- W4285490696 hasConceptScore W4285490696C2777525834 @default.
- W4285490696 hasConceptScore W4285490696C2777938653 @default.
- W4285490696 hasConceptScore W4285490696C2778461978 @default.
- W4285490696 hasConceptScore W4285490696C2779338263 @default.
- W4285490696 hasConceptScore W4285490696C2779343474 @default.
- W4285490696 hasConceptScore W4285490696C2779878957 @default.
- W4285490696 hasConceptScore W4285490696C2780483514 @default.
- W4285490696 hasConceptScore W4285490696C71924100 @default.
- W4285490696 hasConceptScore W4285490696C86803240 @default.
- W4285490696 hasIssue "2" @default.
- W4285490696 hasLocation W42854906961 @default.
- W4285490696 hasOpenAccess W4285490696 @default.
- W4285490696 hasPrimaryLocation W42854906961 @default.
- W4285490696 hasRelatedWork W1583697856 @default.
- W4285490696 hasRelatedWork W1865071181 @default.
- W4285490696 hasRelatedWork W2289227211 @default.
- W4285490696 hasRelatedWork W2340641211 @default.
- W4285490696 hasRelatedWork W2810788428 @default.
- W4285490696 hasRelatedWork W3047187536 @default.
- W4285490696 hasRelatedWork W3092580075 @default.
- W4285490696 hasRelatedWork W3097111364 @default.
- W4285490696 hasRelatedWork W3215197450 @default.
- W4285490696 hasRelatedWork W4310160016 @default.
- W4285490696 hasVolume "24" @default.
- W4285490696 isParatext "false" @default.
- W4285490696 isRetracted "false" @default.
- W4285490696 workType "article" @default.